Amgen Faces Suit, Subpoenas Over Alleged Tying
A health fund has filed a proposed class action lawsuit against biotech company Amgen Inc., alleging it is illegally tying and pricing the sales of three of its oncology products....To view the full article, register now.
Already a subscriber? Click here to view full article